S&P reaffirms Sirtex after new offer from Chinese managerBY ALEX BURKE | TUESDAY, 8 MAY 2018 12:23PMASX-listed healthcare firm Sirtex, whose investors include some of Australia's leading fund managers, will remain in the S&P/ASX 200 after its US takeover has been postponed in light of a new offer. Read more: Sirtex, US, ASX, S&P, Australia, CDH Investments, US-based Varian Medical Systems, BNP Paribas, Carpe Diem Asset Management, Federal Court, Foreign Investment Review Board, HSBC, IDP Education, J.P. Morgan, William Roberts Lawyers, Yarra Capital Related News |
Editor's Choice
ASIC hits back at parliament: 'Simply not realistic'
The financial regulator has hit back at suggestions it isn't doing enough to deal with community complaints.
The risks and opportunities in advice: SIAA
This year's Stockbrokers and Investment Advisers Association (SIAA) Conference will take a deep dive into how major financial advice reforms will impact superannuation funds and how they are preparing to help Australians particularly retirees access advice.
AMP Advice partners with BlackRock and Lonsec
Through the partnership, AMP Advice will introduce a new category of tailored managed portfolio solutions.
Succession planning troubles family offices: J.P. Morgan
Global family offices remain deeply concerned about how to prepare the next generation to inherit a vast fortune as almost 30% do not have a structured approach to help them, a new study from J.P. Morgan reveals.
Products
Featured Profile
Fiona Mann
HEAD OF LISTED EQUITIES AND ESG
BRIGHTER SUPER
BRIGHTER SUPER
Brighter Super head of listed equities and ESG Fiona Mann was shaped by a childhood steeped in military-like discipline and global nomadism. Andrew McKean writes.